Clinical outcomes following complete bioresorption of the Absorb everolimus-eluting bioresorbable scaffold: Four-year results from the ABSORB III trial

被引：1
|
作者：
Kereiakes, Dean [1 ]
Ellis, Stephen [2 ]
Stone, Gregg [3 ]
机构：
[1] Christ Hosp, Cincinnati, OH 45219 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Columbia Univ, Med Ctr, NewYork Presbyterian Hosp, Cardiovasc Res Fdn, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 72卷 / 13期
关键词：
D O I：
10.1016/j.jacc.2018.08.1150
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-61
引用
收藏
页码：B27 / B27
页数：1
相关论文
共 50 条
  • [21] ABSORB everolimus-eluting bioresorbable vascular scaffold systems for the sealing of unstable plaques
    Gori, T.
    Qu, Z.
    Muxel, S.
    Hink, U.
    Schulz, E.
    Wenzel, P.
    Jabs, A.
    Munzel, T.
    EUROPEAN HEART JOURNAL, 2013, 34 : 485 - 485
  • [22] Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial
    Wiebe, Jens
    Byrne, Robert A.
    Alfonso, Fernando
    Maeng, Michael
    Bradaric, Christian
    Kretov, Evgeny
    Cuesta, Javier
    Kuna, Constantin
    Ibrahim, Tareq
    Rivero, Fernando
    Heugl, Mira
    Christiansen, Evald H.
    Joner, Michael
    Schunkert, Heribert
    Laugwitz, Karl-Ludwig
    Kastrati, Adnan
    Cassese, Salvatore
    EUROINTERVENTION, 2022, 17 (16) : 1348 - +
  • [23] Assessment of the bioresorption process utilising intravascular ultrasound derived echogenicity analyses and vasomotion testing of the ABSORB bioresorbable everolimus-eluting vascular scaffold. A substudy of the ABSORB Cohort B trial
    Heo, Jung Ho
    Brugaletta, Salvatore
    Onuma, Yoshinobu
    Farooq, Vusim
    Bruining, Nico
    Garcia-Garcia, Hector M.
    Serruys, Patrick W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B175 - B175
  • [24] First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients with de Novo Native Coronary Artery Lesions
    Chevalier, Bernard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B11 - B11
  • [25] The long-term impact of post-procedural asymmetry and eccentricity of bioresorbable everolimus-eluting scaffold and metallic everolimus-eluting stent on clinical outcomes in the ABSORB II trial
    Katagiri, Y.
    Serruys, P. W. S.
    Macaya, C. M.
    Ormiston, J. O.
    Hill, J. H.
    Lang, I. M. L.
    Egred, M. E.
    Fajadet, J. F.
    Lesiak, M. L.
    Wykrzykowska, J. J. W.
    Piek, J. J. P.
    Sabate, M. S.
    Windecker, S. W.
    Chevalier, B. C.
    EUROPEAN HEART JOURNAL, 2018, 39 : 545 - 545
  • [26] Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
    Onuma, Yoshinobu
    Chevalier, Bernard
    Ono, Masafumi
    Cequier, Angel
    Dudek, Dariusz
    Haude, Michael
    Carrie, Didier
    Sabate, Manel
    Windecker, Stephan
    Rapoza, Richard
    West, Nick E. J.
    Reith, Sebastian
    Almeida, Manuel de Sousa
    Campo, Gianluca
    Iniguez, Andres
    Serruys, Patrick W.
    EUROINTERVENTION, 2020, 16 (11) : E938 - E941
  • [27] The Long-Term Impact of Post-Procedural Asymmetry and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
    Katagiri, Yuki
    Serruys, Patrick W.
    Macaya, Carlos
    Ormiston, John A.
    Hill, Jonathan
    Lang, Irene M.
    Egred, Mohaned
    Fajadet, Jean
    Lesiak, Maciej
    Wykrzykowska, Joanna J.
    Piek, Jan J.
    Sabate, Manel
    Windecker, Stephan
    Chevalier, Bernard
    Onuma, Yoshinobu
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (10) : 1013 - 1015
  • [28] A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan
    Kimura, Takeshi
    Kozuma, Ken
    Tanabe, Kengo
    Nakamura, Sunao
    Yamane, Masahisa
    Muramatsu, Toshiya
    Saito, Shigeru
    Yajima, Junji
    Hagiwara, Nobuhisa
    Mitsudo, Kazuaki
    Popma, Jeffrey J.
    Serruys, Patrick W.
    Onuma, Yoshinobu
    Ying, Shihwa
    Cao, Sherry
    Staehr, Peter
    Cheong, Wai-Fung
    Kusano, Hajime
    Stone, Gregg W.
    EUROPEAN HEART JOURNAL, 2015, 36 (47) : 3332 - 3342
  • [29] Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial
    Xu, Bo
    Yang, Yuejin
    Han, Yaling
    Huo, Yong
    Wang, Lefeng
    Qi, Xiangqian
    Li, Jifu
    Chen, Yundai
    Kuo, Hai-Chien
    Ying, Shih-Wa
    Cheong, Wai-Fung
    Zhang, Yunlong
    Su, Xiaolu
    Popma, Jeffery J.
    Gao, Runlin
    Stone, Gregg W.
    EUROINTERVENTION, 2018, 14 (05) : 554 - 561
  • [30] ABSORB III PK: Pharmacokinetics of Everolimus Eluted from the Absorb Bioresorbable Vascular Scaffold (BVS)
    Rizik, David
    Cannon, Louis A.
    Ellis, Stephen
    Stone, Gregg W.
    Kennedy, Maureen
    Piard-Ruster, Karine
    Staehr, Peter
    Kereiakes, Dean J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B210 - B210
12345